If blood clotting is affected for a longer period of time it can cost your life! Read this article to understand more about ...

Haemophilia is a genetic disorder that impairs the bloods ability to clot normally Women with mild or severe haemophilia have ...

Hemophilia impairs the body's capacity to form blood clots, a process essential for haemostasis following bleeding. This ...

Many people in Kenya may be living with an undiagnosed rare bleeding disorder known as hemophilia, which may put them at risk ...

Hemophilia is a rare, inherited bleeding disorder in which the blood does not clot normally due to a deficiency in essential ...

Pfizer’s Hympavzi (marstacimab) has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...

“The theme for World Haemophilia Day 2025, ‘Access for All: Women and Girls Bleed Too’, highlights the need to raise ...

Haemophilia is a genetic bleeding disorder that occurs rarely due to deficiencies in clotting factors, leading to unheeded or ...

Australia: In a significant development for Hemophilia B treatment, a multi-year follow-up study has shown that a single ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Caplin Steriles, a subsidiary of Caplin Point Laboratories, received USFDA approval for Phytonadione Injectable Emulsion USP ...